comparemela.com

Latest Breaking News On - Oxford university innovation fund - Page 1 : comparemela.com

Brainomix announces new partnership with Pixyl to expand its offering with multiple sclerosis solution

/PRNewswire/ Brainomix, an AI-powered medtech solutions company, has announced a new partnership with Pixyl, an award-winning, Grenoble-based medtech.

France generalUnited kingdomUnited statesMichalis papadakisPrnewswire brainomixMichel dojatJeff wyrtzenInstitut gustave roussyFlorence forbesSenan doyleParis saint joseph hospital groupHospital health researchUniversity of oxfordMarketing business developmentBoehringer ingelheim venture fundCredit agricole

Visionable and Brainomix announce strategic partnership to tackle bottlenecks in time-sensitive stroke care pathway

/PRNewswire/ Visionable, a real-time clinical collaboration platform enabling virtual healthcare models, and Brainomix, an AI-powered medtech solutions.

United kingdomCity ofTower hamletsVaishali patelPrnewswire visionableRob hughesRiaz rahmanJeff wyrtzenSue charlesLynda sibsonSajid alamEllie gaddUniversity of oxfordMarketing business developmentBoehringer ingelheim venture fundTencent holdings

Brainomix; Visionable: Visionable and Brainomix announce strategic partnership to tackle bottlenecks in time-sensitive stroke care pathway

Benefits of combining Visionable's virtual platform with Brainomix's e-Stroke imaging already demonstrated at Ipswich HospitalKENT, England and OXFORD, England, Nov. 10, 2022 /PRNewswire/

United kingdomCity ofTower hamletsVaishali patelPrnewswire visionableRob hughesRiaz rahmanJeff wyrtzenSue charlesLynda sibsonKostenloser wertpapierhandelSajid alamEllie gaddUniversity of oxfordMarketing business developmentBoehringer ingelheim venture fund

Brainomix and Bridge Biotherapeutics, Inc Announce Partnership to Utilize Brainomix AI-Powered e-ILD Software for Automated Assessment of Idiopathic Pulmonary Fibrosis (IPF)

/PRNewswire/ Brainomix, the AI-powered medtech solutions company, and Bridge Biotherapeutics, Inc., a South Korean clinical-stage biotechnology company.

South koreaSouth koreanRepublic of koreaPeter georgePrnewswire brainomixJeff wyrtzenAgnes jungSue charlesBrainomix biotherapeuticsTencent holdingsOxford university innovation fundBiotherapeutics incUniversity of oxfordMarketing business developmentBoehringer ingelheim venture fundBridge biotherapeutics inc

Brainomix Expands Leadership Team with Appointment of Melissa Strange as Chief Financial Officer and Jérôme Galbrun as Chief Revenue Officer

Melissa Strange MBA, from Closed Loop Medicine, joins as Chief Financial OfficerJérôme Galbrun PhD, joins as Chief Revenue Officer, ex-Philips Global LeaderThe company has more than doubled

United kingdomUnited statesKostenloser wertpapierhandelMichalis papadakisPrnewswire brainomixJeff wyrtzenSue charlesBusiness school of lyonsBoehringer ingelheim venture fundTencent holdingsGe healthcareTechnology innovationUniversity of oxfordOxford brookes universityMarketing business developmentTokyo institute of technology

vimarsana © 2020. All Rights Reserved.